Harvard Infectious Diseases In Adults 2026

Harvard Infectious Diseases in Adults 2026

Adult Infectious Diseases Study and Clinical Review

Harvard Infectious Diseases in Adults 2026 is a digital study product covering antimicrobial stewardship, resistant infections, HIV, fungal disease and other adult infectious-disease topics. This file purchase does not provide Harvard registration, publisher account access or CME credit.

File counts and sizes below are retained store-listed details, not an independently verified file inventory. The original event’s credit eligibility does not apply to this purchase.

Presented by leading faculty and nationally recognized infectious diseases specialists, this advanced CME program delivers practical clinical guidance for the prevention, diagnosis, and treatment of common, emerging, resistant, and difficult-to-manage infectious diseases in adult patients.

The curriculum combines expert-led lectures, multidisciplinary workshops, case-based learning, and interactive discussions to support evidence-based infectious diseases practice across inpatient, outpatient, and critical care settings.

---

Course Information

---

Course Overview

This intensive infectious diseases course reviews state-of-the-art strategies for diagnosing, preventing, and treating infectious diseases in both immunocompetent and immunocompromised patients.

The program emphasizes:

• Antimicrobial stewardship
• Resistant bacterial and fungal infections
• HIV prevention and management
• COVID-19 and respiratory viral infections
• Mycobacterial diseases
• Endocarditis and musculoskeletal infections
• Tropical and emerging infectious diseases
• Sepsis and critical care infectious diseases
• Vaccines and preventive infectious diseases medicine

The curriculum integrates current guidelines, evolving treatment strategies, rapid diagnostics, and multidisciplinary infectious diseases management approaches applicable to modern clinical practice.

---

Key Learning Objectives

Participants will learn to:

• Apply updated infectious diseases treatment guidelines
• Optimize antimicrobial selection and duration of therapy
• Recognize emerging infectious diseases and resistant pathogens
• Utilize rapid infectious diseases diagnostics effectively
• Manage infections in immunocompromised hosts
• Diagnose and treat fungal, viral, and mycobacterial infections
• Develop multidisciplinary care strategies for complex infections
• Improve antimicrobial stewardship and resistance prevention
• Apply evidence-based management strategies for HIV and STIs
• Integrate current approaches to sepsis and critical care infectious diseases

---

Resistant & Complex Infections

The course provides advanced updates in the management of:

• MRSA and VISA infections
• ESBL-producing Gram-negative organisms
• Carbapenem-resistant infections
• Vancomycin-resistant enterococci (VRE)
• Resistant fungal infections
• Nontuberculous mycobacterial infections (NTM)
• Prosthetic and device-related infections
• Endocarditis and cardiac device infections

Participants review modern antimicrobial strategies and multidisciplinary treatment approaches for highly resistant and difficult-to-treat infections.

---

HIV, Viral & Emerging Infectious Diseases

Specialized sessions cover:

• HIV prevention and treatment updates
• HIV opportunistic infections
• PEP and PrEP strategies
• Long COVID and respiratory viral infections
• Hepatitis B and C updates
• Emerging viral infections
• Global infectious diseases
• Vaccine-preventable diseases
• Polio and avian influenza updates

The program also explores evolving public health challenges and global infectious diseases trends affecting clinical practice.

---

Antimicrobial Stewardship & Clinical Decision-Making

Dedicated educational sessions include:

• Antimicrobial stewardship strategies
• Optimizing empiric antibiotic therapy
• De-escalation of antimicrobial treatment
• Intravenous vs oral antimicrobial selection
• Rapid infectious diseases diagnosis
• Preventing antimicrobial resistance
• Infection management in persons who inject drugs (PWID)

The curriculum emphasizes practical, evidence-based infectious diseases decision-making designed to improve patient outcomes while reducing resistance and unnecessary antimicrobial exposure.

---

Fungal, Tropical & Mycobacterial Diseases

The course includes focused reviews of:

• Antifungal diagnostics and therapy
• Systemic fungal infections
• Tropical medicine updates
• Tuberculosis and latent TB infection
• Drug-resistant TB
• Pulmonary and extrapulmonary NTM infections
• Tick-borne and mosquito-borne diseases

Participants gain updated clinical insight into both common and rare infectious diseases encountered in modern practice.

---

Critical Care & Hospital-Based Infectious Diseases

Hospital-focused infectious diseases topics include:

• Sepsis and critical care ID
• CNS infections and meningitis
• Orthopedic and musculoskeletal infections
• Complicated urinary tract infections
• Intra-abdominal infections
• Skin and soft tissue infections
• Transplant-related infections
• Hematologic malignancy-associated infections

The program emphasizes multidisciplinary inpatient infectious diseases management and evidence-based treatment strategies for hospitalized patients.

---

Who Should Take This Course?

This course is ideal for:

• Infectious diseases physicians
• Internists
• Hospital medicine physicians
• Pulmonary & critical care physicians
• Emergency medicine physicians
• Family medicine physicians
• Pharmacists
• Nurse practitioners
• Physician assistants

It is particularly valuable for clinicians seeking updated expertise in antimicrobial stewardship, HIV medicine, resistant infections, fungal diseases, sepsis, and complex infectious diseases management.

---

Original Program Topics

The outline below describes the original May 4–8, 2026 program, not an independently verified list of delivered files. Live Q&A labels refer to the original event. Unrecorded or unreleased-session notices are retained.

1. 01 Advancing Patient Care Through Antimicrobial Stewardship

2. 02 Update on Antifungal Diagnostics and Therapy

3. 03 Plenary The Future of Global Public Health Lessons from HIV

4. 04 Live Q&A Dr. Linda-Gail Bekker

5. 05 Eye and ENT Infections What You Need to Know in 2026

6. 06 Live Q&A Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour

7. 07 Multidisciplinary Panel Workshop 1 Resistant Gram-Positive Infections

8. 08 Multidisciplinary Panel Workshop 2 Resistant Gram-Negative Infections

9. 09 Live Q&A Drs. Alyssa Letourneau, Roby Bhattacharyya, Cecilia Li, and Tiffany Wu

10. 10 C. difficile Update, the Gut Microbiome, and Pre- and Probiotics

11. 11 Skin and Soft Tissue Infections Current Best Practices for Clinicians

12. 12 Live Q&A Drs. Sandra Nelson and Elizabeth Hohmann

13. 13 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy

14. 14 Infections in Hematologic Malignancies and Stem Cell Transplantation

15. 15 Flummoxing Cases in Fungal Infections

16. 16 Live Q&A Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett

17. 17 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections

18. 18 Updates on COVID-19, Including Long COVID

19. 19 Navigating New Vaccines Updates and Recommendations

20. 20 Pre- and Post-Exposure Prophylaxis for HIV and STIs

21. 21 What’s New in the Care of People with HIV in 2026

22. 22 Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections

23. 23 Live Q&A Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton

24. 24 Self-Paced Study HIV Perinatal HIV Infection

25. 25 Self-Paced Study HIV Perinatal Metabolic Complications of HIV

26. 26 Self-Paced Study HIV Perinatal CROI Updates

27. 27 Self-Paced Study HIV Perinatal HIV Resistance

28. 28 Introduction to TB, Latent TB Infection, and Drug-Susceptible TB

29. 29 Drug-Resistant TB and TB in Special Populations

30. 30 Live Q&A Drs. Rocio Hurtado and Jodian Pinkney

31. 31 Bronchiectasis and NTM Infections Anatomic and Clinical Approaches

32. 32 The Latest on Major Respiratory Viral Infections

33. 33 Innovations in HBV and HCV Care Updates for 2026

34. 34 Live Q&A Drs. Nesli Basgoz, Arthur Kim, and Michael Ison

35. 35 Live New England Journal of Medicine Clinicopathologic Conference (CPC) Please note This event will not be recorded

36. 36 Clinical Challenges in Tropical Medicine A 2026 Review

37. 37 Global Infectious Diseases Case-Based Updates

38. 38 Live Q&A Dr. Edward T. Ryan

39. 39 Multidisciplinary Panel Workshop 3 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Pulmonary

40. 40 Multidisciplinary Panel Workshop 4 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Extrapulmonary

41. 41 Live Q&A Drs. Rocio Hurtado, Michael Lanuti, Christopher Richards, Kristen Hysell, Alex Rock, and Alyssa Letourneau

42. 42 Encephalitis and Meningitis Guidelines and Best Practices

43. 43 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia

44. 44 Live Q&A Drs. Allan Tunkel and Kimon Zachary

45. 45 Bone and Joint infections A Conceptual Framework

46. 46 Staphylococcus aureus Déjà Vu All Over Again

47. 47 Live Q&A Drs. Sandra Nelson and Henry Chambers

48. 48 Multidisciplinary Panel Workshop 5 Native Bone Infections

49. 49 Multidisciplinary Panel Workshop 6 Orthopedic Device Infections Prosthetic Joint Infections

50. 50 Live Q&A Drs. Sandra Nelson, Hayden Box, F. Joseph Simeone, and Jeremy Goverman VIDEO NOT RELEASE

51. 51 New and Emerging Viruses Clinical Insights for Frontline Providers and ID Specialists

52. 52 KEYNOTE Polio The Unfinished Story

53. 53 Live Q&A Drs. Martin Hirsch and David Oshinsky VIDEO NOT RELEASE

54. 54 Intra-abdominal Infections A Conceptual Framework

55. 55 Urinary Tract Infections A Conceptual Framework

56. 56 Critical Care ID and Sepsis for the ID Clinician

57. 57 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell VIDEO NOT RELEASE

58. 58 Multidisciplinary Workshop 7 Management of Complex Intra-abdominal Infections

59. 59 Multidisciplinary Workshop 8 Management of Complex Urinary Tract Infections

60. 60 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, Peter Fagenholz, Vincent Wu, Kristen Hung, and Lori Jones

61. 61 Endocarditis and Cardiac Device Infections

62. 62 The Syndemic of SUD and Infection Updated Approaches for 2026

63. 63 Live Q&A Drs. Molly Paras and Jennifer Johnson

64. 64 Multidisciplinary Workshop 9 Management of Endocarditis

65. 65 Multidisciplinary Workshop 10 Management of Cardiac Device Infections

66. 66 Live Q&A Drs. Molly Paras, Anne Duckles, Arminder Jassar, Shaan Khurshid, and Evin Yucel

Delivery and Access

Google Drive files are for self-paced study. No CME points, certificate, live faculty interaction, Harvard registration, publisher account or guaranteed access to every original session is included.

Original-program reference: Harvard Medical School: Infectious Diseases in Adults 2026 program information.